A process is described for the delivery of a therapeutic polynucleotide to limb muscle tissue suffering from or potentially suffering from Muscular Dystrophy. The polynucleotide is inserted into a mammalian limb vessel such as an artery. Delivery efficiency and distribution is enhanced by combining injection of a solution containing the polynucleotide with the use of an externally applied cuff.

 
Web www.patentalert.com

> Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity

~ 00385